Skip to content

    HEG Limited

    HEG
    Capital Goods·14 Feb 2025
    Management Summary

    HEG reported a mixed Q3 FY25, with a 15.12% YoY decline in revenue to INR 477 crores, but a strong 76.36% YoY increase in EBITDA to INR 194 crores and a 164.86% YoY rise in standalone PAT to INR 98 crores. The company maintained its debt-free status with a robust treasury of INR 1,000 crores and operated its plant at 80% capacity utilization. While electrode pricing remains under pressure, the demerger of the anode business is underway, valued at INR 3,200 crores, aiming to unlock significant shareholder value.

    Highlights

    5
    • EBITDA for Q3 FY25 was INR 194 crores, a significant increase from INR 110 crores in Q3 FY24, representing a 76.36% YoY growth.

    • Standalone Net Profit After Tax for Q3 FY25 was INR 98 crores, a substantial rise from INR 37 crores in Q3 FY24, marking a 164.86% YoY growth.

    • The company remains long-term debt-free and holds a treasury size of nearly INR 1,000 crores as of December 31, 2024.

    • HEG's plant operated at approximately 80% capacity utilization (at 100,000 tons), which management claims is the highest among graphite electrode companies in the Western world.

    • The demerger process for the anode business is progressing, with an estimated valuation of INR 3,200 crores for the new entity, aiming to unlock shareholder value.

    Concerns

    4
    • Revenue from operations for Q3 FY25 declined to INR 477 crores from INR 562 crores in the corresponding quarter of the previous financial year, a 15.12% YoY decrease.

    • Electrode pricing remains under pressure due to subdued demand, leading to a narrowing of profit spread despite stable needle coke prices.

    • Global crude steel production (excluding China) showed only a marginal growth of 0.2% in CY2024, and China's increased steel exports (111 million tons) are impacting graphite electrode demand in other markets.

    • The potential 7.5% reciprocal import duty from the U.S. could reduce HEG's EBITDA margin on U.S. exports from 16-17% to 10%.

    What Changed2

    vs Q4 FY25

    Guidance items6 → 3 (-3)Risks discussed4 → 3 (-1)

    Key financials

    Single quarter

    05 metrics
    1. 01Revenue from operations₹477 Cr-15.1%YoY
    2. 02EBITDA₹194 Cr+76.4%YoY
    3. 03Net Profit After Tax (Standalone)₹98 Cr+1.6%YoY
    4. 04Net Profit After Tax (Consolidated)₹83 Cr+88.6%YoY
    5. 05EBITDA Margin40.7%

    Order Book

    medium confidence

    Execution

    3 to 6 months for raw material to electrode production, 2 to 4 to 5 months for production

    Composition

    Exports(geography)
    66.0%

    "The company's capacity utilization remains 80% at 100,000 tons, with 80-85% of current quarter's production already sold and at least 50% for the next quarter (April-June). The lead time from raw material purchase to electrode sale is 3-6 months, meaning current discussions relate to Q3 of the calendar year."

    Source:
    Prepared remarks

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    ₹1,700 crores

    Debt

    Gross ₹0 crores · Net ₹-1,000 crores

    M&A

    GrafTech

    acquisition · pending regulatory

    Liquidity

    Cash ₹1,000 crores

    Company is long-term debt-free with a treasury of nearly INR 1,000 crores as of December 31, 2024.

    Guidance & targets

    3
    CategoryTargetPriority
    Other
    Demerger completion and listing of new entity
    By end of 2025
    High
    Capacity
    Anode plant operational status
    Fully operational
    High
    Capex
    Anode plant total capex
    INR 1,700-1,750 crores
    High

    What to watch in Q4 FY25

    5

    Demerger completion and listing of new entity

    End of 2025
    CurrentPapers re-filed with SEBI, delayed by 2 months.
    TargetApprovals by end of year, listing of new entity.

    Why it matters

    This is a key strategic initiative to unlock shareholder value for the anode business.

    Our demerger scheme is in the process. It got delayed by about 2 months due to our share split, which was also important to do, and the papers have now been re-filed with SEBI. We hope to get all the required approvals by the end of this year.

    Risks & concerns

    3
    RiskSeverity

    Electrode pricing pressure and narrowing profit spreads

    Subdued demand for electrodes is keeping prices under pressure, and stable needle coke prices are narrowing profit margins.Management acknowledged

    medium

    Impact of China's steel exports and stalled EAF shift

    China's high steel exports (111 million tons) and slower-than-expected shift to EAFs create an oversupply of Chinese electrodes, affecting global demand dynamics, but Chinese electrodes are generally lower quality (not UHP) and not a direct threat to HEG's core market.Management downplayed

    medium

    Potential U.S. reciprocal import duties

    If the U.S. imposes a 7.5% reciprocal duty, it would directly impact the profitability of HEG's exports to one of its largest markets, reducing EBITDA margin on those exports to 10%.Management acknowledged

    medium

    Q&A highlights

    8

    “PwC and ISEC reports on the fair valuation of the asset, which will be the new entity, that is close to INR3,200 crores. That is the fair value of that asset. So, once this process has been done entirely, it will create immense value for the shareholders.”

    Provides a specific valuation for the demerged entity, offering clarity on the potential shareholder value unlock.

    asked by Praful Kumar

    3 min read6 chapters

    Detailed Narrative

    01

    Global Steel Market & Electrode Demand Dynamics

    Global crude steel production in CY2024 declined by 0.8% to 1,883 million tons, with ex-China production showing a marginal 0.2% growth. India, however, saw a 6.3% rise to nearly 150 million tons. China's steel exports surged to 111 million tons, the highest in 8 years, impacting global demand for graphite electrodes. Despite this, management remains optimistic about the medium to long-term outlook, citing the irreversible decarbonization shift and approximately 100 million tons of new greenfield electric arc furnace (EAF) capacity expected worldwide.

    02

    Q3 FY25 Financial Performance Overview

    HEG reported a 15.12% YoY decline in revenue from operations to INR 477 crores in Q3 FY25, compared to INR 562 crores in Q3 FY24. Despite this, EBITDA significantly increased by 76.36% YoY to INR 194 crores (from INR 110 crores in Q3 FY24), resulting in an EBITDA margin of 40.67%. Standalone Net Profit After Tax surged by 164.86% YoY to INR 98 crores, and consolidated PAT rose by 88.63% YoY to INR 83 crores. The company maintained its long-term debt-free status with a treasury of nearly INR 1,000 crores as of December 31, 2024.

    03

    Operational Efficiency & Capacity Utilization

    HEG's plant operated at approximately 80% capacity utilization for its 100,000-ton capacity, which management claims is the highest among Western graphite electrode companies. The company exports about two-thirds of its production to over 30 countries. While electrode pricing is under pressure, management believes HEG remains the lowest-cost producer globally. The lead time from raw material procurement to electrode sale is 3-6 months, with 80-85% of the current quarter's capacity already sold and at least 50% for the next quarter.

    04

    Demerger and Anode Plant Project Progress

    The demerger scheme for the anode business is in process, delayed by 2-3 months due to a share split, with re-filed papers with SEBI. Approvals are expected by the end of 2025, aiming to unlock shareholder value. The new anode entity is estimated to be valued at INR 3,200 crores. The anode plant, with an increased capacity of 20,000 tons (from 10,000 tons), is located on 105 acres in Dewas, with INR 100 crores already spent. The total capex for this project is estimated at INR 1,700-1,750 crores, with the plant expected to be fully operational by September 2026.

    05

    Strategic Investment in GrafTech

    HEG has increased its investment limit in foreign stocks, specifically in GrafTech, aiming for a stake exceeding 10%. The rationale is GrafTech's unique backward integration with 70% self-sufficiency in needle coke, a critical raw material, which allows for price stability. Management views GrafTech as undervalued, with its market cap being half of HEG's despite having twice the electrode capacity and backward integration, believing its prices are likely to appreciate significantly. This investment leverages HEG's substantial treasury, which was yielding 6-8% returns.

    06

    Competitive Landscape and Pricing Strategy

    The global graphite electrode industry (ex-China) has a nameplate capacity of 700,000 tons, with current utilization estimated at 60-65%, leading to production of 4.5-5 lakh tons. While some Western competitors have announced 15-20% price increases, HEG is not proactively raising prices, preferring to follow market acceptance. Management notes that Chinese electrodes, while contributing to oversupply, are generally of lower quality (HP grade, not UHP) and do not pose a direct threat to HEG's high-quality UHP segment. The potential 7.5% U.S. reciprocal duty, if implemented, would reduce HEG's EBITDA margin on U.S. exports from 16-17% to 10%.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.